Finch Therapeutics Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	25.12	71.04	133.48	99.71	42.19
Cash & Short-Term Investments	25.12	71.04	133.48	99.71	42.19
Cash Growth	-64.63%	-46.78%	33.87%	136.36%	-
Accounts Receivable	-	0.14	0.49	1.1	1.75
Other Receivables	-	-	-	-	3
Receivables	-	0.14	0.49	1.1	4.75
Prepaid Expenses	0.72	3.37	8.58	5.36	1.69
Total Current Assets	25.85	74.55	142.55	106.16	48.63
Property, Plant & Equipment	27.18	48.69	24.69	7	3.78
Goodwill	-	-	18.06	18.06	18.06
Long-Term Deferred Charges	-	32.9	32.9	33.91	32.9
Other Long-Term Assets	2.35	6.8	7.17	0.2	0.21
Total Assets	55.37	162.94	225.37	165.34	103.57
Accounts Payable	0.14	1.1	3.74	2.62	0.66
Accrued Expenses	1.54	9.09	9.93	5.23	3.96
Current Portion of Leases	1.72	3.43	1.13	-	-
Current Unearned Revenue	-	-	-	3.37	2.38
Other Current Liabilities	0.68	1.07	-	0.27	0.33
Total Current Liabilities	4.08	14.69	14.79	11.49	7.33
Long-Term Debt	-	14.65	-	1.81	-
Long-Term Leases	28.4	34.26	4.89	-	-
Long-Term Unearned Revenue	-	-	-	10.26	8.29
Long-Term Deferred Tax Liabilities	-	3.46	3.46	3.46	3.46
Other Long-Term Liabilities	-	0.17	-	0.99	0.88
Total Liabilities	32.49	67.23	23.15	28	19.95
Common Stock	0	0	0.05	0.01	0.11
Additional Paid-In Capital	373.28	371.35	363.17	7.11	3.85
Retained Earnings	-350.4	-275.64	-161	-102.84	-63.49
Total Common Equity	22.89	95.71	202.22	-95.72	-59.54
Shareholders' Equity	22.89	95.71	202.22	137.34	83.62
Total Liabilities & Equity	55.37	162.94	225.37	165.34	103.57
Total Debt	30.13	52.34	6.02	1.81	-
Net Cash (Debt)	-5	18.7	127.46	97.9	42.19
Net Cash Growth	-	-85.33%	30.19%	132.07%	-
Net Cash Per Share	-3.12	11.76	97.54	360.60	173.47
Filing Date Shares Outstanding	1.61	1.6	1.58	0.28	0.26
Total Common Shares Outstanding	1.61	1.6	1.58	0.28	0.26
Working Capital	21.76	59.86	127.76	94.68	41.3
Book Value Per Share	14.25	59.75	127.69	-342.18	-229.61
Tangible Book Value	22.89	95.71	184.17	-113.78	-77.59
Tangible Book Value Per Share	14.25	59.75	116.29	-406.73	-299.25
Machinery	0.87	6.05	4.76	3.11	2.29
Construction In Progress	-	0.32	0.33	2.64	-
Leasehold Improvements	-	13.97	13.89	2.14	2.75

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.